Good Chemistry’s STATS guide is meant as a tool for consumer education in identifying quality.
Doctors need more education on recommending cannabis and the legal ramifications.
State legal protections and medical research should spur insurance companies to tackle cannabis.
Developing SOPs for cultivation practices and sales protocols help companies stay compliant.
The stigma associated with cannabis and its federal illegality prevent the normalization of cannabis business.
States like New York, Massachusetts, Pennsylvania and Connecticut could quickly become hubs for the medical cannabis industry.
